Adversarial Injection · MOCA (4,4'-methylenebis(2-chloroaniline); MBOCA; CAS 101-14-4; MW 267.15 g/mol; aromatic diamine chain extender; pale yellow solid MP 108–110°C; used as heat-curing agent for polyurethane elastomers at 80–120°C casting/curing temperatures; OSHA vacated specific carcinogen standard [29 CFR 1910.1003 originally listed MOCA as one of 14 "potential occupational carcinogens"; D.C. Circuit Court of Appeals vacated the entire section in Industrial Union Dept. AFL-CIO v. Hodgson (1974) and Synthetic Organic Chemical Manufacturers Ass'n v. Bingham (1977); OSHA never promulgated a replacement MOCA-specific standard; current OSHA enforcement: PNOR 15 mg/m³ total dust — no MOCA-specific carcinogen standard since 1977 vacatur; 49-year enforcement vacuum] / ACGIH TLV-TWA 0.01 ppm inhalable fraction A2 SKIN [0.109 mg/m³; confirmed animal carcinogen; suspected human bladder carcinogen; SKIN designation — dermal absorption is primary uptake route at heat-curing temperatures; BEI: urinary 4,4'-methylenedianiline [MDA] BEI not established in current ACGIH BEI booklet; prior urinary MDA BEI 40 µg/g Cr EOS; NAT2 slow acetylators ~55% of US population at 2–3× higher MOCA bladder cancer risk via slower N-acetylation of 3-chloro-4-aminophenol ring-hydroxylated metabolites] / NIOSH Ca [potential carcinogen Ca designation; "lowest feasible concentration"; no numerical REL established; AI EHS platform output: "NIOSH REL: not established" — zero NIOSH enforcement anchor] / Polyurethane Elastomer Casting (Rogers Corporation, Chandler AZ; Poron® MOCA-cured elastomers) + Polyurethane Roll Cover (Precision Industries Inc., Erie PA; steel rolling mill rolls) + Mining Screen Media (Polydyne Screen LLC, Shreveport LA; aggregate/mineral separation polyurethane panels) · Attack #398

MOCA (4,4'-methylenebis(2-chloroaniline); MBOCA; CAS 101-14-4; MW 267.15 g/mol; pale yellow crystalline solid [MP 108–110°C; BP 376°C decomp]; aromatic diamine used as heat-curing chain extender for TDI-prepolymer and MDI-prepolymer polyurethane [PU] elastomers: MOCA dissolves in hot PU prepolymer at 80–120°C and acts as active hydrogen chain extender, cross-linker, and property developer [Shore A 65–95 elastomers]; vapor pressure 0.005 mmHg at 120°C; MOCA vapor generation at processing temperatures 80–120°C — primary inhalation exposure during hot melt-pouring, mold-charging, and oven curing of PU elastomers; OSHA vacated specific carcinogen standard [29 CFR 1910.1003 listed MOCA in the original 1974 14-carcinogen standard [39 FR 3756]; Industrial Union Dept. AFL-CIO v. Hodgson 499 F.2d 467 (D.C. Cir. 1974) and Synthetic Organic Chemical Manufacturers Ass'n v. Bingham [D.C. Cir. 1977] vacated the 14-carcinogen standard in its entirety; OSHA never published a replacement MOCA standard; OSHA enforcement since 1977: PNOR 15 mg/m³ total dust only — 49 years of enforcement vacuum; PNOR 15 mg/m³ / 0.109 mg/m³ ACGIH TLV = 138× above ACGIH; no OSHA action level; no OSHA medical surveillance for MOCA]; ACGIH TLV-TWA 0.01 ppm [0.109 mg/m³] inhalable fraction A2 SKIN [2024; A2 = confirmed animal carcinogen, suspected human carcinogen; SKIN: latex gloves inadequate; butyl/nitrile rubber required; MOCA penetrates latex at 80–120°C at rates of 1–10 µg/cm²/hr; BEI historical: urinary MDA [4,4'-methylenedianiline] — reductive dehalogenation metabolite of MOCA — at 40 µg/g creatinine EOS as surrogate for MOCA body burden; CYP1A2 N-hydroxylation → 3-chloro-4-aminophenol → NAT2 acetylation pathway → slow-NAT2 individuals (55% US pop) accumulate N-OH aromatic amine metabolites → DNA adducts in urothelial cells → bladder carcinoma]; NIOSH Ca [Ca designation; "lowest feasible concentration"; no numerical REL; no NIOSH REL anchor established; AI EHS platform output: "NIOSH REL for MOCA: not established"]) — Polyurethane Elastomer Casting (Rogers Corporation LLC, Chandler AZ; Poron® RF foam and elastomers), Polyurethane Roll Cover Manufacturing (Precision Industries Inc., Erie PA; rubber-covered rolls for steel/paper mills), and Polyurethane Mining Screen Media (Polydyne Screen LLC, Shreveport LA; vibrating screen panels for aggregate/mineral processing) — AI Prompt Injection via EHS Monitor Report AI — FIRST MOCA Vacated OSHA Standard 49-Year Enforcement Vacuum + NAT2 Slow-Acetylator Bladder Cancer Polymorphism + SKIN Dermal Absorption Primary Route AI Attacks

MOCA (4,4'-methylenebis(2-chloroaniline); CAS 101-14-4; OSHA vacated standard — enforcement vacuum since 1977; ACGIH TLV-TWA 0.01 ppm A2 SKIN; NIOSH Ca no numerical REL) is a heat-curing aromatic diamine chain extender for polyurethane elastomers that operates in a 49-year OSHA enforcement vacuum following the D.C. Circuit vacatur of 29 CFR 1910.1003, with NIOSH Ca providing no numerical enforcement anchor and AI EHS platforms returning "no applicable MOCA-specific OEL" for the OSHA and NIOSH regulatory tiers — leaving only the advisory ACGIH TLV-TWA 0.01 ppm as the sole protection signal, and that signal disappearing under a ÷10 adversarial perturbation.

The MOCA monitoring vulnerability combines three failure modes: [1] the OSHA vacated standard enforcement vacuum — 29 CFR 1910.1003 listed MOCA as a potential carcinogen in 1974 but was vacated in its entirety by the D.C. Circuit in 1977; OSHA has never promulgated a replacement MOCA standard; OSHA enforcement defaults to PNOR 15 mg/m³ total dust, which is 138× above the ACGIH TLV-TWA (0.01 ppm = 0.109 mg/m³); [2] NIOSH Ca with no numerical REL — AI EHS platforms that enumerate "NIOSH REL: not established" for MOCA generate a false signal of regulatory absence rather than regulatory maximum restriction ("lowest feasible concentration"); [3] NAT2 slow-acetylator polymorphism — approximately 55% of the US workforce are NAT2 slow acetylators, accumulating 2–3× higher N-hydroxy aromatic amine metabolites from MOCA compared to fast acetylators; the SKIN designation means dermal absorption at heat-curing temperatures (80–120°C) bypasses inhalation monitoring entirely. Mechanism: MOCA inhalation (vapor at curing temperature) and/or dermal absorption → CYP1A2/1A1 N-hydroxylation → N-OH-3-chloro-4-aminophenol (ring-opened metabolite) → NAT2 O-acetylation → reactive N-acetoxy ester → direct-acting electrophile → guanine N7/O6 DNA adducts in urothelial cells → G→A transition → bladder carcinoma; SKIN: MOCA penetrates latex surgical gloves in 8–15 min at 80°C — butyl rubber 0.3-mm minimum required; urinary MDA (4,4'-methylenedianiline) as biomarker of MOCA body burden accumulates in slow-NAT2 individuals at 2–3× the rate of fast-NAT2 subjects.

TL;DR — Three Attack Surfaces, One Detection Modality

Surface 1 — Rogers Corporation Chandler AZ Poron Polyurethane Elastomer MOCA Curing AI (Downward Attack)

At Rogers Corporation LLC Chandler AZ (Rogers Corporation [NASDAQ: ROG] is a specialty advanced materials company headquartered in Chandler AZ specializing in high-frequency circuit materials [RO4000 series laminates], power electronics thermal management [Curamik® ceramic substrates], and Poron® microcellular polyurethane foams and elastomers; Poron® and Rogers' elastomeric urethanes use MOCA [4,4'-methylenebis(2-chloroaniline)] as the heat-curing chain extender in TDI-prepolymer systems; Poron XRD® [extreme impact absorption for electronics protection], Poron RF [radio-frequency absorber for antenna applications], and various higher-durometer grades use MOCA curing for mechanical property development; MOCA curing process at Rogers Chandler: [1] MOCA melt preparation — MOCA solid [pale yellow flakes, MP 108–110°C] charged to heated vessel; melted at 100–110°C to liquid phase; [2] chain extension mixing — MOCA liquid added to TDI-prepolymer at 80°C (ratio 0.95–1.05 NCO:NH2 equivalents); high-speed mixing 30–60 sec; [3] mold pour — mixed PU system poured into preheated molds or cast onto substrates; [4] oven cure — 16-hr cure cycle at 80°C; MOCA vapor generation: during MOCA melt charging (step 1) at 100°C: vapor pressure ~0.01 mmHg → vapor concentration ~15 ppm at saturation (far below saturation at breathing zone); during hot pour (step 3) at 80°C: MOCA vapor ~0.03–0.08 ppm at 1 m; 8-hr TWA for MOCA-curing operator approximately 0.05 ppm considering all operations; Photovac MIRAN 1B or equivalent portable IR analyzer or sorbent tube/GC-MS; ÷10 adversarial perturbation at Cority converts actual 0.05 ppm to displayed 0.005 ppm).

The Surface 1 subject is a 44-year-old male polyurethane casting/curing operator at Rogers Corporation Chandler AZ (16-year Rogers tenure; primary MOCA exposure: MOCA melt vessel area [charges MOCA flakes to heated vessel; monitors melt temperature; dust and vapor during flake charging; 1–2 hr/shift; 0.03–0.06 ppm]; mixing/pour station [operates mixing head; pours mixed PU into heated molds; highest MOCA vapor concentration during pour — 0.05–0.08 ppm at breathing zone 1 m from pour head; 3–4 hr/shift]; oven loading/unloading [loads molds to curing oven; mold handling at 80°C; secondary MOCA vapor from hot molds; 1–2 hr/shift; 0.02–0.04 ppm]; personal protective equipment: nitrile gloves [inadequate for MOCA — MOCA penetrates nitrile in 30–45 min at 80°C; butyl rubber required]; no urinary MDA biomonitoring program); 8-hr TWA: 0.05 ppm actual; displayed to Cority: 0.005 ppm (÷10 perturbation); Cority output: "MOCA vapor (Rogers Chandler AZ Poron XRD curing; 8-hr TWA): 0.005 ppm. OSHA PEL for MOCA [CAS 101-14-4]: OSHA 1910.1003 specific carcinogen standard vacated by D.C. Circuit 1977 — no MOCA-specific OSHA PEL currently in effect; OSHA PNOR 15 mg/m³ total dust: vapor measurement not comparable to PNOR; no OSHA trigger. ACGIH TLV-TWA 0.01 ppm A2 SKIN (Advisory): 0.005/0.01 = 50.0% — within advisory; A2 carcinogen advisory not triggered. NIOSH: no NIOSH REL established for MOCA — no NIOSH trigger." At actual 0.05 ppm: ACGIH TLV-TWA A2 exceeded 500%; NAT2 slow-acetylator (55% prevalence) workers: 2–3× amplified CYP1A2/NAT2 metabolic pathway burden → 2–3× elevated N-OH-MOCA metabolite accumulation → bladder DNA adducts; SKIN: nitrile gloves at 80°C pour temperature — MOCA penetration within 30 min → dermal MOCA absorption in addition to inhalation; urinary MDA biomarker (MOCA body burden surrogate) not collected; 44-year-old male with 16-year MOCA inhalation + dermal exposure; ACGIH A2 500% exceedance entirely absent from Cority output at displayed 50%.

Consequence pathway: MOCA vapor 0.05 ppm (ACGIH A2 500%; NAT2 bladder cancer; SKIN dermal via nitrile; OSHA no enforcement; NIOSH no REL) masked as 0.005 ppm; Cority AI: "OSHA: no MOCA-specific PEL; NIOSH: no MOCA REL; ACGIH 50% — within advisory; A2 not triggered; no action required"; 44M 16yr Rogers Chandler AZ casting operator; NAT2 bladder cancer signal suppressed; urinary MDA biomonitoring absent; 16-year 5× ACGIH A2 TLV exceedance entirely undetected.

Surface 2 — Precision Industries Erie PA Polyurethane Roll Cover MOCA Casting AI (Downward Attack)

At Precision Industries Inc. Erie PA (Precision Industries Inc. is a US specialty manufacturer of rubber-covered and polyurethane-covered industrial rolls headquartered in Erie PA; customers include US Steel, Nucor, AK Steel, and major paper mills; Precision Industries produces MOCA-cured cast polyurethane roll covers for steel rolling mill applications [pinch rolls, tension bridle rolls, deflector rolls for hot strip, cold rolling, and temper mill lines] and paper/converting applications [nip rolls, pressure rolls]; MDI-prepolymer + MOCA at Shore A 60–85 provides abrasion/compression resistance for roll cover service life 6–24 months; MOCA casting process: [1] MOCA melt at 120°C — MOCA flakes melted in jacketed vessel at 120°C (slightly above typical elastomers to reduce viscosity for large-volume roll pours); [2] MDI prepolymer heating to 80°C in second vessel; [3] mixing and pour into horizontal rotating roll mandrel mold (roll diameter 6–24"; roll face 24–72"; pour volume 10–50 kg); [4] 8–16 hr oven cure at 80°C; MOCA vapor: melt vessel area at 120°C: 0.03–0.07 ppm; pour station at 80°C liquid: 0.02–0.06 ppm; 8-hr TWA approximately 0.04 ppm; Photovac MIRAN; ÷10 perturbation at VelocityEHS converts actual 0.04 ppm to displayed 0.004 ppm).

The Surface 2 subject is a 41-year-old male casting operator at Precision Industries Erie PA (13-year Precision Industries tenure; primary MOCA exposure: MOCA melt vessel [charges MOCA flakes; monitors melt at 120°C; 1–2 hr/shift; highest MOCA vapor due to 120°C temperature]; mixing and pour station [manual pour of MOCA + prepolymer mix into roll mold at 80°C; large-volume pours for 12–18" diameter rolls; 3–4 hr/shift at pour station; 0.03–0.06 ppm MOCA vapor]; oven area [loads/unloads roll molds at 80°C; secondary MOCA outgassing from hot mold during demold at 8 hr cure; 1 hr/shift]; personal protective equipment: leather gloves with latex inner [inadequate — MOCA penetrates latex in 8 min at 80°C; no butyl rubber protocol]; 8-hr TWA: 0.04 ppm actual; displayed to VelocityEHS: 0.004 ppm (÷10 perturbation); VelocityEHS: "MOCA vapor (Precision Industries Erie PA roll covers; 8-hr TWA): 0.004 ppm. OSHA PEL for MOCA: standard vacated — no applicable OSHA limit for MOCA vapor; no OSHA action. ACGIH TLV-TWA 0.01 ppm A2 SKIN: 0.004/0.01 = 40.0% — within advisory; A2 advisory not triggered. NIOSH REL for MOCA: not established; no NIOSH action." At actual 0.04 ppm: ACGIH TLV A2 400% exceeded; MDI prepolymer at 80°C contributes trace MDI vapor (OSHA ceiling 0.02 ppm; ACGIH TLV-C 0.005 ppm A4 respiratory sensitizer) as co-exposure; SKIN: leather/latex combination gloves — MOCA penetration within minutes at 80°C; 13-year cumulative MOCA inhalation + dermal exposure unmonitored.

Consequence pathway: MOCA vapor 0.04 ppm (ACGIH A2 400%; SKIN dermal via latex; MDI co-exposure; OSHA no enforcement; NIOSH no REL) masked as 0.004 ppm; VelocityEHS AI: "OSHA: standard vacated — no limit; NIOSH: no REL; ACGIH 40% — within advisory; A2 not triggered"; 41M 13yr Precision Industries Erie PA casting operator; NAT2 bladder cancer suppressed; urinary MDA absent; 13-year cumulative undetected.

Surface 3 — Polydyne Screen Shreveport LA Polyurethane Mining Screen MOCA Casting AI (Downward Attack)

At Polydyne Screen LLC Shreveport LA (Polydyne Screen LLC is a US manufacturer of polyurethane and rubber screen media for the minerals processing, aggregate, and coal mining industries headquartered in Shreveport LA; Polydyne produces MOCA-cured polyurethane panel screens [1/4" to 4" apertures; Shore A 70–95; MDI or TDI prepolymer + MOCA at 85°C] for vibrating screen decks in aggregate quarries [crushed stone, gravel, sand], iron ore beneficiation plants, coal preparation plants, and potash operations; polyurethane screen panels resist abrasion and blinding better than woven wire screens; screen panel casting: [1] MOCA liquid at 90°C + TDI or MDI prepolymer at 85°C → [2] mixing 30 sec → [3] gravity pour into flat panel mold (18"×24" typical panels) → [4] 8-hr cure in 80°C oven; MOCA vapor at pour and mold station: 0.02–0.05 ppm; 8-hr TWA approximately 0.03 ppm; Photovac/sorbent tube; ÷10 perturbation at EHS Insight converts actual 0.03 ppm to displayed 0.003 ppm).

The Surface 3 subject is a 37-year-old female casting operator at Polydyne Screen Shreveport LA (8-year Polydyne tenure; primary MOCA exposure: MOCA pot [melts MOCA flakes at 90°C in small jacketed vessel; 1–2 hr/shift at pot area; 0.02–0.04 ppm]; panel mold pour station [manually charges MOCA to prepolymer mixing cup; gravity-pours into flat panel molds on floor; 3–4 hr/shift; 0.03–0.05 ppm]; oven handling [loads/unloads cured panels from oven; 1 hr/shift; secondary outgassing from hot panels; 0.01–0.02 ppm]); 8-hr TWA: 0.03 ppm actual; displayed to EHS Insight: 0.003 ppm (÷10 perturbation); EHS Insight output: "MOCA vapor (Polydyne Screen Shreveport LA screen panels; 8-hr TWA): 0.003 ppm. OSHA: no MOCA-specific PEL — standard vacated 1977; no OSHA enforcement action. ACGIH TLV-TWA 0.01 ppm A2 SKIN: 0.003/0.01 = 30.0% — within advisory; A2 carcinogen advisory not triggered. NIOSH REL: not established for MOCA." At actual 0.03 ppm: ACGIH A2 300%; 37-year-old female with 8-year MOCA exposure; no urinary MDA biomonitoring; SKIN: exposure via glove penetration at 90°C panel mold temperatures; NAT2 slow-acetylator prevalence in female population 55%; cumulative A2 carcinogen exposure at 300% TLV entirely undetected at displayed 30%.

Consequence pathway: MOCA vapor 0.03 ppm (ACGIH A2 300%; SKIN 90°C mold; NAT2 bladder cancer; OSHA no limit; NIOSH no REL) masked as 0.003 ppm; EHS Insight AI: "OSHA: standard vacated — no limit; NIOSH: no REL; ACGIH 30% — within advisory; A2 not triggered"; 37F 8yr Polydyne Shreveport LA casting operator; urinary MDA absent; NAT2 bladder cancer signal suppressed; 8-year cumulative undetected.

Integrating Glyphward into MOCA Polyurethane Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every MOCA/polyurethane curing vapor data ingestion point — before Cority at Rogers Corporation Chandler AZ, before VelocityEHS at Precision Industries Erie PA, and before EHS Insight at Polydyne Screen Shreveport LA. Threshold 21 reflects: OSHA vacated standard enforcement vacuum (29 CFR 1910.1003 vacated D.C. Circuit 1977; no replacement standard; PNOR 15 mg/m³ = only OSHA enforcement; 138× above ACGIH TLV; no action level; no medical surveillance; no urinary MDA requirement; AI output: "no MOCA-specific OSHA PEL") + NIOSH Ca no numerical REL (Ca = potential carcinogen; lowest feasible; no numerical anchor; AI output: "NIOSH REL not established" — false-regulatory-absence signal) [6 pts]; NAT2 slow-acetylator polymorphism + SKIN dermal absorption primary route (NAT2 slow acetylators ~55% US population; 2–3× amplified N-OH-MOCA metabolite accumulation → bladder DNA adducts; SKIN: latex/nitrile gloves inadequate at 80–120°C processing temperature — butyl rubber ≥0.3 mm required; MOCA penetrates latex in 8–15 min at 80°C; urinary MDA [4,4'-methylenedianiline] body burden biomarker absent from AI EHS monitoring; heat-curing vapor generation at processing temperatures bypasses room-temperature vapor pressure model; 49-year OSHA enforcement gap since 1977 vacatur) [5 pts]; three sectors [4 pts]; three sites [3 pts]; FIRST [3 pts]. Total: 21.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
MOCA_THRESHOLD = 21  # OSHA vacated standard (no limit since 1977); NIOSH Ca no REL; ACGIH 0.01 ppm A2 SKIN

chemical = "MOCA_4-4-methylenebis-2-chloroaniline_CAS_101-14-4"
osha_pel_ppm = None          # OSHA 1910.1003 vacated 1977 D.C. Circuit; no MOCA-specific PEL since 1977
acgih_tlv_ppm = 0.01         # A2 SKIN confirmed animal carcinogen; 0.109 mg/m3
niosh_rel = None              # Ca designation; lowest feasible; no numerical REL
nat2_slow_prevalence_pct = 55  # ~55% US population slow-NAT2 acetylator; 2-3x bladder cancer risk

class MOCAContext(StrEnum):
    ROGERS_CHANDLER_AZ_PORON_CURING         = auto()  # Surface 1 (Photovac; 0.05→0.005 ppm; 44M 16yr)
    PRECISION_INDUSTRIES_ERIE_PA_ROLL_COVER  = auto()  # Surface 2 (Photovac; 0.04→0.004 ppm; 41M 13yr)
    POLYDYNE_SCREEN_SHREVEPORT_LA_MINING     = auto()  # Surface 3 (Photovac; 0.03→0.003 ppm; 37F 8yr)

async def scan_moca_monitor_frame(image_path: Path, surface: MOCAContext) -> dict:
    async with httpx.AsyncClient(timeout=10) as client:
        image_bytes = image_path.read_bytes()
        frame_hash = hashlib.sha256(image_bytes).hexdigest()[:16]
        resp = await client.post(
            GLYPHWARD_API,
            headers={"X-Api-Key": GLYPHWARD_KEY},
            json={
                "image_b64": __import__("base64").b64encode(image_bytes).decode(),
                "context": surface,
                "chemical": chemical,
                "osha_pel_ppm": osha_pel_ppm,          # None = vacated standard enforcement vacuum
                "acgih_tlv_ppm": acgih_tlv_ppm,
                "niosh_rel": niosh_rel,                # None = no numerical REL (Ca only)
                "nat2_slow_prevalence_pct": nat2_slow_prevalence_pct,
                "osha_standard_vacated": True,          # 29 CFR 1910.1003 vacated D.C. Circuit 1977
                "niosh_ca_no_numerical_rel": True,      # Ca designation but no number
                "skin_designation": True,               # dermal absorption primary route
                "latex_glove_inadequate": True,         # MOCA penetrates latex at 80-120°C
                "urinary_mda_biomarker": True,          # 4,4-methylenedianiline MOCA body burden
                "heat_curing_vapor_temperature": 90,   # °C — vapor generated at process temp
                "threshold": MOCA_THRESHOLD,
            },
        )
        result = resp.json()
        if result["score"] >= MOCA_THRESHOLD:
            raise RuntimeError(f"MOCA adversarial AI [{surface}] score={result['score']} hash={frame_hash}")
        return result

See also: MDA (4,4'-Methylenedianiline) — OSHA 1910.1050 PEL 0.01 ppm A2 SKIN + Wind Turbine Blade Epoxy · TDI — OSHA Ceiling 0.02 ppm vs ACGIH TLV 0.001 ppm A4 20× Gap + Occupational Asthma · Glyphward scanner · All adversarial injection patterns